Sanofi (ADR) (NYSE:SNY)
A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Clint35
(68.90)
Submitted: 1/27/2012 6:27:56 PM :
Start Price:
$36.91
SNY Score:
-2.08
It's yielding 3.57% and 5 stars
Recs
balcobulls
(40.18)
Submitted: 1/8/2012 10:04:32 PM :
Start Price:
$35.97
SNY Score:
-1.47
As soon as Europe is not throwing this stock around, Sanofi will boom! Great fundamentals!
Recs
market8
(41.19)
Submitted: 12/16/2011 4:53:30 PM :
Start Price:
$34.86
SNY Score:
-3.28
Valuation too cheap.
Recs
ruinas
(< 20)
Submitted: 12/15/2011 5:29:13 PM :
Start Price:
$35.02
SNY Score:
-3.61
drug production and pipeline will boost earnings
Recs
CraigMiles
(64.53)
Submitted: 10/30/2011 8:17:32 AM :
Start Price:
$36.78
SNY Score:
-4.44
Undervalued plus ~3% to 4% dividend.
The value has been tricky to estimate as the company has so much equity. If I only consider the present value of the ability to generate FCF I get a value of $49 (Std. Dev = $6)
Recs
willabe13
(< 20)
Submitted: 9/13/2011 2:43:48 PM :
Start Price:
$32.22
SNY Score:
+1.29
India based biotech in under-represented market
Recs
GrizWin
(< 20)
Submitted: 9/6/2011 12:09:41 PM :
Start Price:
$34.38
SNY Score:
-7.66
Dividend makes is "safer" in the short run but with pipeline and genzyme long term also looks good
Recs
Keekers44
(88.47)
Submitted: 9/3/2011 12:09:41 PM :
Start Price:
$34.20
SNY Score:
-8.60
This stock is a Cramer favorite with a decent 3.8% yeild. Cramer believes this company has a low valuation, and is an accidental high yeilder. Ken Fisher of Fisher Asset Management recently increased holdings to over 14,750,000 shares.
Recs
dipster12000
(30.70)
Submitted: 8/25/2011 3:06:48 PM :
Start Price:
$35.75
SNY Score:
-11.24
Its got everything going for it. Great yield, size, growth rate etc. Take advantage of the euro panic.
Recs
3igenValue
(30.98)
Submitted: 8/23/2011 2:32:21 AM :
Start Price:
$35.86
SNY Score:
-14.93
O'Shaughnessy Value Screen +Basic Dividend Valuation
Recs
gilboy7
(< 20)
Submitted: 8/10/2011 7:36:25 PM :
Start Price:
$30.98
SNY Score:
+1.54
Strong pipeline and nice dividend make SNY a compelling buy at this price.
Recs
mtrade1
(< 20)
Submitted: 6/15/2011 3:04:54 PM :
Start Price:
$36.39
SNY Score:
-3.49
want 2 get it on the down turn. down 4% strong co.
Recs
Laice1
(44.32)
Submitted: 6/3/2011 5:38:09 AM :
Start Price:
$37.94
SNY Score:
-5.11
A good defensive stock with a good divi.
Recs
FuriousGreen
(56.25)
Submitted: 5/2/2011 1:52:52 PM :
Start Price:
$38.57
SNY Score:
-1.92
Caters to the baby boomer market, which will suddenly demand their products like a junky demands heroin.
Recs
RXDOC73
(98.62)
Submitted: 2/6/2011 8:07:51 AM :
Start Price:
$32.97
SNY Score:
+10.68
Growth and the money to back it!
Recs
Recs
noguarantees
(61.95)
Submitted: 12/8/2010 3:19:12 AM :
Start Price:
$31.40
SNY Score:
+9.31
SNY is a good investment because it does not depend on reviews of brokers and experts such as Zacks. Take for example NKBP: Zacks gives it as "strong buy" for the past nine months, in fact NKBP continues to fall
Recs
Recs
smartorbandit
(62.53)
Submitted: 11/23/2010 8:07:35 AM :
Start Price:
$31.56
SNY Score:
+4.86
good SNY but news and estimates lying on NKBP (nasdaq)
Recs
Sinner75
(57.41)
Submitted: 11/11/2010 7:56:34 AM :
Start Price:
$33.40
SNY Score:
+0.47
cheap, under valued, over looked
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 140 : 1 2 3 4 5 6 7 Next »